Journal of Peking University (Health Sciences) ›› 2026, Vol. 58 ›› Issue (4): 860-864. doi: 10.19723/j.issn.1671-167X.2026.04.025

Previous Articles     Next Articles

Efficacy and safety of laparoscopic nephron-sparing surgery for giant renal angio-myolipoma

Peichen DUAN*, Le YU*, Fan ZHANG, Xiaofei HOU, Guoliang WANG, Yichang HAO*(), Shudong ZHANG*()   

  1. Department of Urology, Peking University Third Hospital, Beijing 100191, China
  • Received:2026-03-03 Online:2026-08-18 Published:2026-05-15
  • Contact: Yichang HAO, Shudong ZHANG
  • Supported by:
    the National Nature Science Foundation of China(82273389); the National Nature Science Foundation of China(82473287)

RICH HTML

  

Abstract:

Objective: Giant renal angiomyolipoma (RAML), typically defined as having a maximum diameter of ≥8 cm, presents formidable surgical challenges and heightened clinical risks. These challenges primarily stem from the tumor's extensive volume, highly enriched but fragile vascularization, and significant susceptibility to spontaneous rupture and life-threatening hemorrhage. This study aims to comprehensively evaluate the clinical effectiveness and safety of laparoscopic nephron-sparing surgery (NSS) for the management of these complex giant lesions. Methods: A retrospective analysis was performed on 45 patients with giant (≥8 cm) RAML who received NSS at Peking University Third Hospital between January 2012 and September 2025. The cohort comprised 11 males and 34 females with a mean age of (40.9±14.1) years and a mean body mass index (BMI) of (23.7±4.0) kg/m2. Preoperatively, 5 patients had a history of spontaneous hemorrhage, and 2 were pregnant. The mean maximum tumor diameter was (10.3±2.2) cm, ranging from 8.0 to 15.4 cm. Surgical procedures included standard laparoscopy (39 cases) and Da Vinci robotic-assisted laparoscopy (6 cases), utilizing either a retro-peritoneal approach (32 cases, 71.1%) or a transperitoneal approach (13 cases, 28.9%). Pathological diagnosis and differentiation were conducted in strict accordance with the 2022 World Health Organization (WHO) classification of tumors. Key outcome measures included operative time, warm ischemia time, estimated blood loss, postoperative complications, and length of postoperative hospital stay. Results: All the 45 operations were successfully completed with complete tumor resection and nephron preservation, although 5 cases required conversion to open surgery due to severe adhesions or bleeding. The operative time was (180.6±55.7) min (range: 86-312 min), the warm ischemia time was (21.9±9.8) min (range: 6-40 min); 36 cases had a warm ischemia time ≤30 min, while a zero-ischemia technique was employed in 3 cases. The postoperative hospital stay was (6.2±2.6) days (range: 3-14 days), and the time to drainage tube removal was (5.1±2.2) days (range: 2-14 days). Postoperative patho-logy confirmed RAML in all cases, and all surgical margins were negative. Postoperative complications included one case of pulmonary infection and one case of renal insufficiency. During a follow-up of 3 to 43 months, no tumor recurrence or significant loss of renal function was documented. Conclusion: NSS for selected patients with giant RAML is effective in preserving renal function while ensuring complete tumor resection, negative margins, and avoiding short-term and long-term complications. Robotic-assisted systems, in particular, offer distinct advantages in complex wound reconstruction and the reduction of surgical complications.

Key words: Renal angiomyolipoma, Nephron-sparing surgery, Laparoscopy, Treatment outcome

CLC Number: 

  • R737.11

Figure 1

Preoperative imaging of a giant renal angiomyolipoma A, CTU examination shows a mass with mixed density anterior to the left kidney, containing fat and soft tissue densities, measuring approximately 12.8 cm×8.1 cm×12.3 cm. Contrast-enhanced scan reveals inhomogeneous enhancement. B, MRI examination shows a roundish mixed-signal mass in the left kidney, measuring approximately 8.9 cm×6.9 cm×10.8 cm, predominantly characterized by short T1 and long T2 signals. CTU, computed tomography urography; MRI, magnetic resonance imaging."

Table 1

Clinical data and observational indicators of 45 patients with giant RAML"

Characteristic Value
Age/years 40.9±14.1
Gender
    Male 11 (24.4)
    Female 34 (75.6)
Body mass index/(kg/m2) 23.7±4.0
Tumor diameter/cm 10.3±2.2
Surgical side
    Left 23 (51.1)
    Right 22 (48.9)
Preoperative imaging suggestive of contralateral RAML
    No 38 (84.4)
    Yes 7 (15.6)
Preoperative estimated residual renal volume/mL 85.4±23.6
Surgical method
    Laparoscopic 39 (86.7)
    Robotic 6 (13.3)
Surgical approach
    Transperitoneal 13 (28.9)
    Retroperitoneal 32 (71.1)
Operative time/min 180.6±55.7
Renal artery clamping time/min 21.9±9.8
Estimated blood loss/mL 100 (10, 1 300)
Postoperative hospital stay/d 6.2±2.6
Time to drainage removal/d 5.1±2.2

Figure 2

Gross specimen of the surgically resected giant renal angiomyolipoma"

1
Nason GJ , Morris J , Bhatt JR , et al. Natural history of renal angiomyolipoma favors surveillance as an initial approach[J]. Eur Urol Focus, 2021, 7 (3): 582- 588.

doi: 10.1016/j.euf.2020.06.004
2
Jorgenson LC , Navin PJ , Adamo D , et al. Imaging and nonsurgical management of renal masses[J]. RadioGraphics, 2025, 45 (1): e240093.

doi: 10.1148/rg.240093
3
陈克伟, 邓绍晖, 刘茁, 等. 肾血管平滑肌脂肪瘤破裂出血的手术时机[J]. 北京大学学报(医学版), 2024, 56 (2): 326- 331.

doi: 10.19723/j.issn.1671-167X.2024.02.020
4
Fernández-Pello S , Hora M , Kuusk T , et al. Management of sporadic renal angiomyolipomas: A systematic review of available evidence to guide recommendations from the European association of urology renal cell carcinoma guidelines panel[J]. Eur Urol Oncol, 2020, 3 (1): 57- 72.

doi: 10.1016/j.euo.2019.04.005
5
Li Z , Yang L , Yang H , et al. Comparison of superselective renal artery embolization versus retroperitoneal laparoscopic partial nephrectomy in ruptured hemorrhagic renal angiomyolipoma: A single-center study[J]. Diseases, 2024, 12 (9): 218.

doi: 10.3390/diseases12090218
6
Tang S , Song Y , Liu Y , et al. Robot-assisted and embolization-assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal angiomyolipoma: A systematic review and meta-analysis[J]. J Rob Surg, 2025, 20 (1): 79.

doi: 10.1007/s11701-025-03026-5
7
Moch H , Amin MB , Berney DM , et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs: Part A: Renal, penile, and testicular tumours[J]. Eur Urol, 2022, 82 (5): 458- 468.

doi: 10.1016/j.eururo.2022.06.016
8
中国抗癌协会泌尿男生殖系肿瘤专业委员会结节性硬化协作组. 结节性硬化症相关肾血管平滑肌脂肪瘤诊疗与管理专家共识[J]. 中国癌症杂志, 2020, 30 (1): 70- 78.
9
Northrup H , Aronow ME , Bebin EM , et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations[J]. Pediatr Neurol, 2021, 123, 50- 66.

doi: 10.1016/j.pediatrneurol.2021.07.011
10
Kobayashi M , Yokoyama M , Yuki H , et al. Natural history and management of ultrasound-detected small renal angiomyolipoma[J]. J Med Ultrasound, 2024, 32 (2): 154- 160.

doi: 10.4103/jmu.jmu_73_23
11
Kuusk T , Biancari F , Lane B , et al. Treatment of renal angiomyolipoma: Pooled analysis of individual patient data[J]. BMC Urol, 2015, 15 (1): 123.

doi: 10.1186/s12894-015-0118-2
12
Lee KH , Tsai HY , Kao YT , et al. Clinical behavior and management of three types of renal angiomyolipomas[J]. J Formos Med Assoc, 2019, 118 (1): 162- 169.

doi: 10.1016/j.jfma.2018.02.012
13
邱敏, 田晓军, 卢剑, 等. 后腹腔镜肾部分切除术治疗巨大(≥ 8 cm)肾错构瘤的技巧探讨[J]. 中国微创外科杂志, 2017, 17 (10): 905- 908.
14
熊芸强, 刘霄强, 陈路遥, 等. 机器人辅助腹腔镜肾部分切除术治疗巨大肾血管平滑肌脂肪瘤的安全性及有效性[J]. 现代泌尿外科杂志, 2021, 26 (11): 927- 929.
15
Nasim A , Azam A , Mufti AF , et al. Giant renal angiomyolipoma (RAML): A case report and literature review[J]. J Pak Med Assoc, 2025, 75 (7): 1131- 1134.

doi: 10.47391/JPMA.21576
16
Zhou X , Chen Q , Xiong Z , et al. Giant renal angiomyolipoma unmasks underlying lymphangioleiomyomatosis: A case report and literature review[J]. Front Med (Lausanne), 2025, 12, 1610464.
17
Su R , Huang T , Gu L , et al. Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study[J]. Cancer Med, 2024, 13 (17): e70181.

doi: 10.1002/cam4.70181
18
Yang Z , Wang F , Lin D , et al. Modified laparoscopic nephron-sparing surgery for large renal hilar angiomyolipoma: Dual-center experience[J]. Front Surg, 2022, 9, 901033.

doi: 10.3389/fsurg.2022.901033
19
Zhang Y , Zhang Z , Li F , et al. Management of renal sinus angiomyolipoma: Modified robotic nephron-sparing surgery in a single center[J]. BMC Urol, 2024, 24 (1): 103.

doi: 10.1186/s12894-024-01492-x
20
Xue Y , Zhang G , Zhang H , et al. Off-clamp robot-assisted nephron-sparing surgery is associated with less operative time and potential for vascular complication in the treatment of renal angiomyolipoma > 4cm: A comparative study[J]. BMC Urol, 2025, 25 (1): 149.

doi: 10.1186/s12894-025-01836-1
[1] Youdong LIU, Yajun LYU, Jie CHEN, Mingde ZANG, Hongda PAN, Xiaowen LIU, Jun LU, Fenglin LIU. Clinical efficacy and safety of totally laparoscopic subtotal gastrectomy with cardia-gastric fundus preservation in middle-upper gastric cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 301-306.
[2] Weihao LI, Xuemin ZHANG, Wei LI, Tao ZHANG, Xiaoming ZHANG. Outcomes of suture-mediated vascular closure device in the closure of left brachial artery access site after thoracic endovascular aortic repair [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 388-392.
[3] Bin LI, Han LIANG. Robotic gastrectomy: Research progress and practical challenges [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 416-422.
[4] Ebrahimi Farin, Zhiqiang FENG, Ebrahimi Faraz, Weihua HAN, Ziyang YU, Kuankuan JIA, Jingang AN. Surgical treatment outcomes of different stages of maxillary medication-related osteonecrosis of the jaw [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 107-114.
[5] Lianfei PAN, Wenjing LI, Ruiyang WANG, Jian JIAO, Zhanqiang CAO, Li GAO, Dong SHI. Short-term efficacy and influencing factors of systemic antibiotics as an adjunct to mechanical periodontal therapy for stages Ⅲ/Ⅳ periodontitis [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 30-36.
[6] Lingfu ZHANG, Gang WANG, Chunsheng HOU, Long CUI, Lixin WANG, Xiaofeng LING, Zhi XU. Laparoscopic modified transcystic biliary drainage for the treatment of biliary stones and diagnosis of biliary disease [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 748-752.
[7] Huanrui WANG, Shicong LAI, Haopu HU, Zehua DING, Tao XU, Hao HU. Efficacy analysis of laparoscopy combined with flexible ureteroscope in the treatment of complex ureteral stricture [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 784-788.
[8] Yuanyuan YANG, Shanshan ZHANG, Guangyan YU, Huijun YANG, Hongyu YANG. Clinical outcomes of partial sialoadenectomy for the treatment of benign tumors in the submandibular gland [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 334-339.
[9] Yifan KANG, Yanjun GE, Xiaoming LV, Shang XIE, Xiaofeng SHAN, Zhigang CAI. One-stage mandibular reconstruction combining iliac flap with immediate implant-based denture [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 78-84.
[10] Kewei CHEN,Zhuo LIU,Shaohui DENG,Fan ZHANG,Jianfei YE,Guoliang WANG,Shudong ZHANG. Clinical diagnosis and treatment of renal angiomyolipoma with inferior vena cava tumor thrombus [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 617-623.
[11] Le YU,Shaohui DENG,Fan ZHANG,Ye YAN,Jianfei YE,Shudong ZHANG. Clinicopathological characteristics and prognosis of multilocular cystic renal neoplasm of low malignant potential [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 661-666.
[12] Wenjing LI,Baozhou ZHANG,Heng LI,Liangpeng LAI,Hui DU,Ning SUN,Xiaofeng GONG,Ying LI,Yan WANG,Yong WU. Tibiotalocalcaneal arthrodesis for end-stage ankle and hindfoot arthropathy: Short- and mid-term clinical outcomes [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 299-306.
[13] Kewei CHEN,Shaohui DENG,Zhuo LIU,Hongxian ZHANG,Lulin MA,Shudong ZHANG. Discussion on the surgical timing of rupture and hemorrhage of renal angiomyolipoma [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 326-331.
[14] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[15] Min QIU,You-long ZONG,Bin-shuai WANG,Bin YANG,Chu-xiao XU,Zheng-hui SUN,Min LU,Lei ZHAO,Jian LU,Cheng LIU,Xiao-jun TIAN,Lu-lin MA. Treatment outcome of laparoscopic partial nephrectomy in patients with renal tumors of moderate to high complexity [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 833-837.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!